MX2007000744A - Conjugados quelantes de n4 mejorados. - Google Patents
Conjugados quelantes de n4 mejorados.Info
- Publication number
- MX2007000744A MX2007000744A MX2007000744A MX2007000744A MX2007000744A MX 2007000744 A MX2007000744 A MX 2007000744A MX 2007000744 A MX2007000744 A MX 2007000744A MX 2007000744 A MX2007000744 A MX 2007000744A MX 2007000744 A MX2007000744 A MX 2007000744A
- Authority
- MX
- Mexico
- Prior art keywords
- chelator
- amine
- radiopharmaceuticals
- functionalised
- chelators
- Prior art date
Links
- 239000002738 chelating agent Substances 0.000 title abstract 6
- 239000012217 radiopharmaceutical Substances 0.000 abstract 3
- 229940121896 radiopharmaceutical Drugs 0.000 abstract 3
- 230000002799 radiopharmaceutical effect Effects 0.000 abstract 3
- KSSJBGNOJJETTC-UHFFFAOYSA-N COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC Chemical compound COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC KSSJBGNOJJETTC-UHFFFAOYSA-N 0.000 abstract 2
- 125000005647 linker group Chemical group 0.000 abstract 2
- 230000008685 targeting Effects 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000001588 bifunctional effect Effects 0.000 abstract 1
- 239000013522 chelant Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 150000003495 technetium Chemical class 0.000 abstract 1
- 229910052713 technetium Inorganic materials 0.000 abstract 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0416062.8A GB0416062D0 (en) | 2004-07-19 | 2004-07-19 | Improved N4 chelator conjugates |
| PCT/GB2005/002807 WO2006008496A2 (en) | 2004-07-19 | 2005-07-19 | Improved n4 chelator conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007000744A true MX2007000744A (es) | 2007-06-25 |
Family
ID=32893775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007000744A MX2007000744A (es) | 2004-07-19 | 2005-07-19 | Conjugados quelantes de n4 mejorados. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7767796B2 (https=) |
| EP (1) | EP1768708B1 (https=) |
| JP (1) | JP5557425B2 (https=) |
| KR (2) | KR20070034064A (https=) |
| CN (1) | CN101128219B (https=) |
| AU (1) | AU2005263942B2 (https=) |
| BR (1) | BRPI0513456A (https=) |
| CA (1) | CA2573384C (https=) |
| ES (1) | ES2628935T3 (https=) |
| GB (1) | GB0416062D0 (https=) |
| MX (1) | MX2007000744A (https=) |
| NO (1) | NO20070348L (https=) |
| RU (1) | RU2360701C2 (https=) |
| WO (1) | WO2006008496A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI448284B (zh) * | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
| CN101732736B (zh) * | 2009-12-02 | 2012-04-04 | 北京师范大学 | 制备锝-99m标记的DTPA-LSA的药盒及制备方法和应用 |
| GB0922014D0 (en) | 2009-12-17 | 2010-02-03 | Ge Healthcare Ltd | Novel integrin binders |
| GB201016206D0 (en) * | 2010-09-27 | 2010-11-10 | Ge Healthcare Ltd | Apoptosis imaging agents |
| RU2465011C1 (ru) * | 2011-04-27 | 2012-10-27 | Общество с ограниченной ответственностью "ИНТЕРА-МЕД" | Радиофармацевтический препарат для диагностики меланомы и ее метастазов |
| GB201110767D0 (en) | 2011-06-24 | 2011-08-10 | Ge Healthcare Ltd | Infection imaging |
| GB201600161D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope purification method |
| RU2655392C1 (ru) * | 2017-03-02 | 2018-05-28 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет" | Способ получения комплекса технеция-99м с октреотидом для диагностики нейроэндокринных опухолей |
| US11844846B2 (en) | 2018-05-16 | 2023-12-19 | Emory University | Styrylbenzothiazole derivatives and uses in imaging methods |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175343A (en) * | 1985-01-14 | 1992-12-29 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| ATE66469T1 (de) * | 1985-01-14 | 1991-09-15 | Neorx Corp | Metall-radionuklid markiertes protein fuer diagnose und therapie. |
| US5242679A (en) * | 1985-01-14 | 1993-09-07 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| US4952393A (en) * | 1987-04-02 | 1990-08-28 | The General Hospital Corporation | Organ infarct imaging with technetium labelled glucarate |
| WO1988007382A2 (en) * | 1987-04-02 | 1988-10-06 | Centocor Cardiovascular Imaging Partners, L.P. | Method for labelling antibodies with a metal ion |
| US5053493A (en) * | 1987-04-02 | 1991-10-01 | Centocor Cardiovascular Imaging Partners, L.P. | Method for labeling antibodies with a metal ion |
| US4994560A (en) * | 1987-06-24 | 1991-02-19 | The Dow Chemical Company | Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
| US5489425A (en) * | 1987-06-24 | 1996-02-06 | The Dow Chemical Company | Functionalized polyamine chelants |
| US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
| US5650134A (en) * | 1993-01-12 | 1997-07-22 | Novartis Ag (Formerly Sandoz Ltd.) | Peptides |
| NO940080L (no) * | 1993-01-12 | 1994-07-13 | Sandoz Ag | Polypeptider , fremgangsmåte for deres fremstilling og farmasöytiske preparater derav |
| CA2232411A1 (en) * | 1995-09-18 | 1997-03-27 | Mallinckrodt Medical, Inc. | (radio) labelled biotin derivatives |
| GR1003661B (el) * | 2000-05-25 | 2001-09-05 | Εθνικο Κεντρο Ερευνας Φυσικων Επιστημων (Εκεφε) "Δημοκριτος"... | ΣΥΝΘΕΣΗ, ΒΙΟΛΟΓΙΚΗ ΚΑΙ ΠΡΟΚΛΙΝΙΚΗ ΑΞΙΟΛΟΓΗΣΗ ΑΝΑΛΟΓΩΝ ΤΗΣ (D-Phe6, Leu-NHEt13, des-Met14)-ΒΟΜΒΕΣΙΝΗΣ (6-14)ΤΡΟΠΟΠΟΙΗΜΕΝΩΝ ΜΕ ΠΑ ΡΑΓΩΓΑ ΤΟΥ 1,4,8,11-ΤΕΤΡΑΑΖΑΕΝΔΕΚΑΝΙΟΥ(1,4,8,11-TETRAAZAUNDECAN E)ΚΑΙ ΕΠΙΣΗΜΑΣΜΕΝΩΝ ΜΕ ΤΕΧΝΗΤΙΟ-99M- ΓΙΑ ΕΦΑΡΜΟΓΗ ΣΤΗΝ ΟΓΚΟΛΟΓ |
| GB0116815D0 (en) * | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
| BRPI0210886B8 (pt) * | 2001-07-10 | 2021-05-25 | Amersham Health As | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal |
| GB0130305D0 (en) | 2001-12-19 | 2002-02-06 | Amersham Plc | Compounds for imaging alzheimers disease |
| WO2005044313A2 (en) * | 2003-11-06 | 2005-05-19 | Amersham Health As | Conjugates of angiotensin ii and an imaging moiety |
| JP2007512321A (ja) * | 2003-11-24 | 2007-05-17 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 造影剤 |
| ATE447417T1 (de) * | 2004-03-04 | 2009-11-15 | Ge Healthcare As | Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie |
-
2004
- 2004-07-19 GB GBGB0416062.8A patent/GB0416062D0/en not_active Ceased
-
2005
- 2005-07-19 US US11/572,161 patent/US7767796B2/en not_active Expired - Lifetime
- 2005-07-19 KR KR1020077001298A patent/KR20070034064A/ko not_active Ceased
- 2005-07-19 JP JP2007522011A patent/JP5557425B2/ja not_active Expired - Lifetime
- 2005-07-19 KR KR1020137002190A patent/KR20130024963A/ko not_active Ceased
- 2005-07-19 EP EP05763654.0A patent/EP1768708B1/en not_active Expired - Lifetime
- 2005-07-19 MX MX2007000744A patent/MX2007000744A/es active IP Right Grant
- 2005-07-19 WO PCT/GB2005/002807 patent/WO2006008496A2/en not_active Ceased
- 2005-07-19 CA CA2573384A patent/CA2573384C/en not_active Expired - Fee Related
- 2005-07-19 RU RU2007101515/04A patent/RU2360701C2/ru not_active IP Right Cessation
- 2005-07-19 BR BRPI0513456-0A patent/BRPI0513456A/pt not_active IP Right Cessation
- 2005-07-19 CN CN2005800297360A patent/CN101128219B/zh not_active Expired - Lifetime
- 2005-07-19 AU AU2005263942A patent/AU2005263942B2/en not_active Ceased
- 2005-07-19 ES ES05763654.0T patent/ES2628935T3/es not_active Expired - Lifetime
-
2007
- 2007-01-18 NO NO20070348A patent/NO20070348L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5557425B2 (ja) | 2014-07-23 |
| AU2005263942A1 (en) | 2006-01-26 |
| WO2006008496A2 (en) | 2006-01-26 |
| EP1768708A2 (en) | 2007-04-04 |
| CN101128219A (zh) | 2008-02-20 |
| RU2360701C2 (ru) | 2009-07-10 |
| CA2573384A1 (en) | 2006-01-26 |
| CN101128219B (zh) | 2012-06-20 |
| US7767796B2 (en) | 2010-08-03 |
| BRPI0513456A (pt) | 2008-05-06 |
| EP1768708B1 (en) | 2017-05-17 |
| ES2628935T3 (es) | 2017-08-04 |
| CA2573384C (en) | 2013-09-10 |
| KR20130024963A (ko) | 2013-03-08 |
| WO2006008496A3 (en) | 2006-07-27 |
| RU2007101515A (ru) | 2008-08-27 |
| JP2008510683A (ja) | 2008-04-10 |
| AU2005263942B2 (en) | 2009-02-26 |
| KR20070034064A (ko) | 2007-03-27 |
| NO20070348L (no) | 2007-02-16 |
| GB0416062D0 (en) | 2004-08-18 |
| US20080131368A1 (en) | 2008-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20070348L (no) | Improved N4 Chelator Conjugates | |
| AU629178B2 (en) | Tri-aza macrocycles and metal complexes thereof | |
| MX2023006274A (es) | Agentes de imagenes de diagnostico del cancer. | |
| EP4424378A3 (en) | Dual mode radiotracer and -therapeutics | |
| WO2007064345A3 (en) | Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use | |
| MX2021013055A (es) | Inhibidores de antigenos de membrana especificos de prostata (psma) como agentes diagnosticos y terapeuticos con radionuclidos. | |
| IL181529A0 (en) | Diagnostic compounds | |
| NZ597136A (en) | Novel conjugates, preparation thereof, and therapeutic use thereof | |
| Pirmettis et al. | Synthesis and characterization of oxotechnetium (V) mixed-ligand complexes containing a tridentate N-substituted bis (2-mercaptoethyl) amine and a monodentate thiol | |
| Van Staveren et al. | S‐Functionalized Cysteine: Powerful Ligands for the Labelling of Bioactive Molecules with Triaquatricarbonyltechnetium‐99m (1+)([99mTc (OH2) 3 (CO) 3]+) | |
| WO2007106544A3 (en) | Chelating conjugates having a substituted aromatic moiety and derivatives thereof | |
| Gillet et al. | A bispidol chelator with a phosphonate pendant arm: synthesis, Cu (II) complexation, and 64Cu labeling | |
| ZA200400143B (en) | Improved chelator conjugates. | |
| ES2962520T3 (es) | Agentes quelantes bifuncionales | |
| Hayes et al. | Influence of functionalized pyridine ligands on the radio/chemical behavior of [MI (CO) 3]+(M= Re and 99mTc) 2+ 1 complexes | |
| Bottorff et al. | PH-controlled coordination mode rearrangements of “Clickable” huisgen-based multidentate ligands with [MI (CO) 3]+(M= Re, 99mTc) | |
| Figueiredo et al. | Synthesis and biological evaluation of 99mTc (I) Tricarbonyl complexes Dual-Targeted at tumoral mitochondria | |
| Abhayawardhana et al. | Complexes possessing rare “tertiary” sulfonamide nitrogen-to-metal bonds of normal length: fac-[Re (CO) 3 (N (SO2R) dien)] PF6 complexes with hydrophilic sulfonamide ligands | |
| NO20051811D0 (no) | Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic | |
| Hayes et al. | Photo-initiated thiol-ene click reactions as a potential strategy for incorporation of [MI (CO) 3]+(M= Re, 99mTc) complexes | |
| CA2381123A1 (en) | Actinium-225 complexes and conjugates for radioimmunotherapy | |
| JP5152821B2 (ja) | 放射線治療用化学毒性剤としての金属トリカルボニル錯体の使用 | |
| Mishra et al. | Synthesis of novel bifunctional Schiff-base ligands derived from condensation of 1-(p-nitrobenzyl) ethylenediamine and 2-(p-nitrobenzyl)-3-monooxo-1, 4, 7-triazaheptane with salicylaldehyde | |
| Ansari et al. | Synthesis of 2-(p-aminobenzyl) derivatives of 1, 4, 7-triazacyclononane-N, N′, N ″-triacetic acid (NOTA) and 1, 4, 7, 10-tetraazacyclododecane-N, N′, N ″, N ″′-tetraacetic acid (DOTA): macrocyclic bifunctional chelating agents useful for antibodies labeling | |
| TW200722418A (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |